Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

Mechanism and prevention of neurotoxicity caused by beta-amyloid peptides: relation to Alzheimer's disease.

Blanchard BJ, Konopka G, Russell M, Ingram VM.

Brain Res. 1997 Nov 21;776(1-2):40-50.

PMID:
9439794
2.

The Ca2+ influx induced by beta-amyloid peptide 25-35 in cultured hippocampal neurons results from network excitation.

Brorson JR, Bindokas VP, Iwama T, Marcuccilli CJ, Chisholm JC, Miller RJ.

J Neurobiol. 1995 Mar;26(3):325-38.

PMID:
7775966
4.

beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity.

Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel RE.

J Neurosci. 1992 Feb;12(2):376-89.

5.

Amyloid beta peptide and NMDA induce ROS from NADPH oxidase and AA release from cytosolic phospholipase A2 in cortical neurons.

Shelat PB, Chalimoniuk M, Wang JH, Strosznajder JB, Lee JC, Sun AY, Simonyi A, Sun GY.

J Neurochem. 2008 Jul;106(1):45-55. doi: 10.1111/j.1471-4159.2008.05347.x. Epub 2008 Jul 1.

6.

Protective effect of colostrinin on neuroblastoma cell survival is due to reduced aggregation of beta-amyloid.

Schuster D, Rajendran A, Hui SW, Nicotera T, Srikrishnan T, Kruzel ML.

Neuropeptides. 2005 Aug;39(4):419-26.

PMID:
15890402
7.

ApoE protects cortical neurones against neurotoxicity induced by the non-fibrillar C-terminal domain of the amyloid-beta peptide.

Drouet B, Fifre A, Pinçon-Raymond M, Vandekerckhove J, Rosseneu M, Guéant JL, Chambaz J, Pillot T.

J Neurochem. 2001 Jan;76(1):117-27.

8.

Attenuation of beta-amyloid neurotoxicity in vitro by potassium-induced depolarization.

Pike CJ, Balázs R, Cotman CW.

J Neurochem. 1996 Oct;67(4):1774-7.

PMID:
8858966
9.

Neuroprotective approaches in experimental models of beta-amyloid neurotoxicity: relevance to Alzheimer's disease.

Harkany T, Hortobágyi T, Sasvári M, Kónya C, Penke B, Luiten PG, Nyakas C.

Prog Neuropsychopharmacol Biol Psychiatry. 1999 Aug;23(6):963-1008. Review.

PMID:
10621945
10.
11.
12.

An endoplasmic-reticulum-specific apoptotic pathway is involved in prion and amyloid-beta peptides neurotoxicity.

Ferreiro E, Resende R, Costa R, Oliveira CR, Pereira CM.

Neurobiol Dis. 2006 Sep;23(3):669-78. Epub 2006 Jul 17.

PMID:
16844381
13.
14.
15.

Amino-terminal deletions enhance aggregation of beta-amyloid peptides in vitro.

Pike CJ, Overman MJ, Cotman CW.

J Biol Chem. 1995 Oct 13;270(41):23895-8.

16.

Protective effect of transforming growth factor-beta 1 on beta-amyloid neurotoxicity in rat hippocampal neurons.

Prehn JH, Bindokas VP, Jordán J, Galindo MF, Ghadge GD, Roos RP, Boise LH, Thompson CB, Krajewski S, Reed JC, Miller RJ.

Mol Pharmacol. 1996 Feb;49(2):319-28.

PMID:
8632765
17.

Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity.

Pike CJ, Walencewicz-Wasserman AJ, Kosmoski J, Cribbs DH, Glabe CG, Cotman CW.

J Neurochem. 1995 Jan;64(1):253-65.

PMID:
7798921
18.
19.

Elevation of beta-amyloid peptide 2-42 in sporadic and familial Alzheimer's disease and its generation in PS1 knockout cells.

Wiltfang J, Esselmann H, Cupers P, Neumann M, Kretzschmar H, Beyermann M, Schleuder D, Jahn H, Rüther E, Kornhuber J, Annaert W, De Strooper B, Saftig P.

J Biol Chem. 2001 Nov 16;276(46):42645-57. Epub 2001 Aug 28.

20.
Items per page

Supplemental Content

Write to the Help Desk